Federal Medical Cannabis Reclassification: Policy Shift Acknowledges Therapeutic Use, Gaps Remain for Patients and Businesses

The Trump administration recently initiated a federal medical cannabis reclassification, a move that acknowledges state-authorized medical cannabis products and state-licensed providers. This decision marks a shift in federal drug policy, which for over five decades maintained that cannabis…